Feature | December 26, 2012

Congress Passes American Medical Isotope Production Act

SNMMI commends Sens. Jeff Bingaman and Lisa Murkowski for leadership

December 26 , 2012 — Congress last week affirmed its dedication to securing a sustainable, domestic supply of molybdenum-99 (Mo-99) as it passed the American Medical Isotope Production Act of 2011 (S.99). The bill, sponsored Sen. Jeff Bingaman (D-N.M.), chair of the Senate Committee on Energy and Natural Resources, and Sen. Lisa Murkowski (R-Ark), was passed out of the Senate by Unanimous Consent and referred to the House Subcommittee on Energy and Environment. S.99 was included in the Conference Agreement for the National Defense Authorization Act for fiscal year 2013. The president is expected to sign the final legislation.


The bill will establish a technology-neutral program to support the production of Mo-99 for medical uses in the United States by non-federal entities. It also calls for the United States to phase out the export of highly enriched uranium for the production of medical isotopes over a period of seven years.


“Sens. Bingaman and Murkowski have shown unwavering commitment to ensuring a stable isotope supply for the United States,” said Frederic H. Fahey, DSc, president of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). “In order for our patients to receive the best medical care, it’s essential that a reliable supply of Mo-99 be available in the United States. We greatly appreciate their efforts in seeing this bill come to fruition.” Also instrumental in moving the legislation forward were Energy and Commerce Chair Fred Upton (MI-6) and Congressman Ed Markey (MA-7).

Mo-99 is an isotope that decays to technetium-99m (Tc-99m), which is used in more than 16.7 million procedures in the United States each year. Tc-99m is utilized in the detection of heart disease, detection and staging of cancer, detection of thyroid disease, study of brain and kidney function, and imaging of stress fractures.


There are currently only eight foreign producers of Mo-99 approved by the U.S. Food and Drug Administration to import the product into the United States — and there are no domestic facilities exist dedicated to the production of Mo-99 for medical uses. The aging foreign reactors regularly experience significant ongoing maintenance issues — frequently causing these reactors to go off-line. In 2009-2010, the Unites States experienced a shortage of Mo-99 that led to the disruption or delay of nuclear medicine procedures for an estimated 50,000 patients each day.


For more information: www.snmmi.org


Related Content

Navidea, Mass General, Tc99m-tilmanocept, vulnerable plaque, cardiovascular disease, Harvard
News | Radiopharmaceuticals and Tracers| July 30, 2015
Navidea Biopharmaceuticals Inc. announced plans to move forward with a joint study of the ability of Tc99m-tilmanocept...
Medraysintell, nuclear medicine, World Market Report, radiopharmaceuticals
News | Nuclear Imaging| July 06, 2015
Medraysintell released its updated World Market Report and Directory on Nuclear Medicine, Edition 2015, in late June,...
nuclear medicine diagnostic market, North America, PET, SPECT, Mordor
News | Nuclear Imaging| June 29, 2015
The Global Nuclear Medicine Diagnostics Market report from Mordor Intelligence revealed that North America accounts for...
Siemens, MES contract, William Osler Health System, Ontario, Canada
News | Cardiac Imaging| June 26, 2015
Canadian hospital William Osler Health System (Osler), based in Ontario, has awarded Siemens Healthcare a Managed...
Siemens, SNMMI 2015, Biograph RT Pro, Symbia Evo, syngo.via for MI
News | Nuclear Imaging| June 11, 2015
At the 2015 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), June 6-10 at the Baltimore...
GE Healthcare, FASTlab 2, FDG Duo, GENtrace cyclotron, PET imaging

FASTlab 2 with FDG Duo cassette image courtesy of GE Healthcare

Technology | June 08, 2015
GE Healthcare announced that it has created a solution to make positron emission tomography (PET) tracers for...
eVance, Kromek, SPECT cameras, CZT, OEM
Technology | June 08, 2015
Kromek announced the launch of eVance, a new generation of cadmium zinc telluride (CZT)-based SPECT (single photon...
Toshiba, Celesteion, Steinberg Diagnostic Medical Imaging, U.S., first
News | PET-CT| June 08, 2015
Steinberg Diagnostic Medical Imaging (SDMI) of Las Vegas has bolstered its capabilities by installing the United...
News | May 29, 2015
National Security Technologies LLC (NSTec) and Henderson, Nevada-based Global Medical Isotope Systems (GMIS) announced...
Mo-99, molybdenum, MURR, NorthStar, production, University of Missouri
News | May 07, 2015
NorthStar Medical Radioisotopes LLC has completed its first production-scale test run of the molybdenum-99 (Mo-99)...
Overlay Init